ScoreCardiology
Stroke risk in atrial fibrillation (CHA2DS2-VASc)
Estimates thromboembolic risk in non-valvular atrial fibrillation to guide anticoagulation.
Updated 5 November 2026
When to use it
Atrial fibrillation or flutter without moderate-severe mitral stenosis or a mechanical valve, at diagnosis and whenever the clinical picture changes.
What it needs
- Heart failure or moderate-severe left ventricular dysfunction
- Hypertension
- Age
- Diabetes mellitus
- Prior stroke, TIA or systemic embolism
- Vascular disease (prior MI, peripheral artery disease or aortic plaque)
- Sex
The points for each answer and the automatic total are in the app.
How to interpret it
The result is read in its clinical context; the app shows it with its units and warnings.
In the app it also calculates: Factors excluding sex (CHA2DS2-VA).
Practical tip
Female sex is a modifier, not a risk factor on its own: a woman with no other factors is low risk. The 2024 ESC guidelines use CHA2DS2-VA, without the sex point.
3 more practical tips in the app.
Reference
- Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263-272.
- Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500-1510.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
